Key facts
- Benjamin J. Hindson has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $10,826,582.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Benjamin J. Hindson
- Location
- Pleasanton, CA
- Summary
- The estimated net worth of Benjamin J. Hindson is at least $10,826,582 dollars as of 02 Mar 2026. Benjamin J. Hindson is the Title: President and Chief Scientific Officer, Director of 10x Genomics, Inc. and owns shares of 10x Genomics, Inc. (TXG) stock worth about $10.83M.
- Signature
- /s/ Randy Wu, as Attorney-in-Fact for Benjamin J. Hindson
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Benjamin J. Hindson and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Change
- Largest disclosed position: 10x Genomics, Inc. ($10,826,582).
- Past-year value change for that position: -$468,072.
Research use
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Benjamin J. Hindson
TXG
Forms 3/4/5
10x Genomics, Inc.
- Holdings value
- $10,826,582
- Past year net change
- -$468,072
- Change %
- -4.1%
- Report period
- 26 Feb 2026
Insider Transactions Reported by Benjamin J. Hindson:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.